NICOLE SPANO: Open Payments
NPI 1295077410 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 26 payments from 8 companies in 2025. Trend: 2023 $196 · 2024 $297 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| ABBVIE INC. | 3 | $47 |
| Alkermes, Inc. | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, SPRAVATO, INVEGA SUSTENNA, INGREZZA, VRAYLAR, REXULTI, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
